Next Generation Sequencing Services market to hit $56.1B by 2035 with 23.5% CAGR, driven by pharma and clinical adoption.

The global Next Generation Sequencing (NGS) Services market, valued at $6.8 billion in 2025, is projected to grow to $8.3 billion in 2026 and reach $56.1 billion by 2035, expanding at a CAGR of 23.5%. This rapid growth is fueled by increasing demand from pharmaceutical and biotechnology sectors for drug development outsourcing, as well as rising clinical adoption of NGS for disease diagnostics like cancer and genetic disorders. Outsourcing NGS services offers cost-effective, high-throughput sequencing and advanced bioinformatics, helping companies and medical institutions overcome the high costs and expertise barriers of in-house sequencing. North America leads the market currently, while Asia Pacific is the fastest-growing region due to healthcare infrastructure investments and disease prevalence.